Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth ▴	Diluted EPS
CVSI	CV Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.79M	-$958.0K	-6.9%	-65.3%	-12.2%	-$0.01
CPHI	China Pharma Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.14M	-$3.19M	-76.9%	-14.0%	-8.5%	-$0.74
AMRN	Amarin Corp PLC Manufacturing · Year ended 2025-12-31 · USD	$213.65M	-$38.80M	-18.2%	-8.4%	-6.5%	-$0.09
LAB	Standard Biotools Inc. Manufacturing · Year ended 2025-12-31 · USD	$85.33M	-$74.90M	-87.8%	-17.7%	-6.2%	-$0.20
JANX	Janux Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.00M	-$113.62M	n/m	-11.9%	-5.6%	-$1.83
IGC	IGC Pharma, Inc. Manufacturing · Year ended 2025-03-31 · USD	$1.27M	-$7.12M	-560.3%	-112.5%	-5.5%	-$0.09
SPRY	ARS Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$84.28M	-$171.30M	-203.3%	-149.9%	-5.5%	-$1.74
ALKS	Alkermes plc. Manufacturing · Year ended 2025-12-31 · USD	$1.48B	$241.66M	16.4%	13.3%	-5.2%	$1.43
PBH	Prestige Consumer Healthcare Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.09B	$190.30M	17.5%	10.1%	-4.3%	$3.91
RCUS	Arcus Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$247.00M	-$353.00M	-142.9%	-55.9%	-4.3%	-$3.29
ENTA	Enanta Pharmaceuticals Inc Manufacturing · Year ended 2025-09-30 · USD	$65.32M	-$81.89M	-125.4%	-126.5%	-3.4%	-$3.84
VTRS	Viatris Inc Manufacturing · Year ended 2025-12-31 · USD	$14.30B	-$3.51B	-24.6%	-23.9%	-3.0%	-$3.00
OGN	Organon & Co. Manufacturing · Year ended 2025-12-31 · USD	$6.22B	$187.00M	3.0%	24.9%	-2.9%	$0.72
ENSC	Ensysce Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$5.07M	-$10.18M	-200.8%	-316.6%	-2.8%	-$3.98
PRGO	Perrigo Co PLC Manufacturing · Year ended 2025-12-31 · USD	$4.25B	-$1.43B	-33.5%	-48.6%	-2.8%	-$10.29
AMPH	Amphastar Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$719.89M	$98.09M	13.6%	12.4%	-1.7%	$2.03
PFE	Pfizer Inc Manufacturing · Year ended 2025-12-31 · USD	$62.58B	$7.77B	12.4%	9.0%	-1.6%	$1.36
JAGX	Jaguar Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$11.51M	-$53.58M	-465.4%	n/a	-1.5%	-$22.97
LIFD	Lftd Partners Inc. Manufacturing · Year ended 2025-12-31 · USD	$36.92M	-$24.86M	-67.3%	-196.8%	-1.1%	-$1.68
PBYI	Puma Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$228.37M	$31.11M	13.6%	23.9%	-0.9%	$0.61
MGNX	Macrogenics Inc Manufacturing · Year ended 2025-12-31 · USD	$149.50M	-$74.62M	-49.9%	-134.2%	-0.3%	-$1.18
ARVN	Arvinas, Inc. Manufacturing · Year ended 2025-12-31 · USD	$262.60M	-$80.80M	-30.8%	-18.6%	-0.3%	-$1.14
NWBO	Northwest Biotherapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$1.38M	-$60.16M	n/m	n/a	-0.3%	-$0.04
BMY	Bristol Myers Squibb Co Manufacturing · Year ended 2025-12-31 · USD	$48.19B	$7.05B	14.6%	38.2%	-0.2%	$3.46
GNLX	Genelux Corp Manufacturing · Year ended 2025-12-31 · USD	$8.0K	-$32.15M	n/m	-278.5%	0.0%	-$0.86

Rows per page: 2550 100